24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pleural Mesothelioma Testicular Mesothelioma
Hospitals & Clinics
specialties & services
A highly experienced medical oncologist, Dr. Gerald Clamon is currently practicing at the Holden Comprehensive Cancer Center in Iowa City. He completed the Washington University School of Medicine in St. Louis and went on to residency at the Barnes-Jewish Hospital. He completed his medical studies with a fellowship at the University of Iowa Hospitals and Clinics and National Institutes of Health in Bethesda. Dr. Clamon specializes in hematology, oncology and treating different types of lung cancer, mainly mesothelioma, which requires a great deal of expertise to be treated effectively. Dr. Gerald Clamon has published several important works in the field, with many being used today to develop improved treatment techniques.
Washington University School of Medicine, St. Louis, MO
Medical School
Barnes-Jewish Hospital, St Louis, MO
Residency
University of Iowa Hospitals and Clinics, Iowa City, IA National Institutes of Health, Bethesda, MD
Fellowship
American Board of Internal Medicine
American Board of Internal Medicine - Oncology
Holden Comprehensive Cancer Center
Languages: English/Spanish
(319) 356-4200
200 Hawkins Dr
Iowa City, Iowa 52242 
Germline mutations predisposing to non-small cell lung cancer.
Clamon, G. H.,Bossler, A. D.,Hejleh, T. A.,Furqan, M.; Fam. Cancer.
See more >>
Differences in clinical trial patient attributes and outcomes according to enrollment setting.
Lamont, E.B., Landrum, M.B., Keating, N.L., Archer, L., Lan, L., Strauss, G.M., Lilenbaum, R., Niell, H.B., Maurer, L.H., Kosty, M.P., Miller, A.A., Clamon, G.H
See more >>
Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
Givens, D.J., Karnell, L.H., Gupta, A.K., Clamon, G.H., Pagedar, N.A., Chang, K.E., Van Daele, D.J., Funk, G.F.; Arch Otolaryngol Head Neck Surg.
See more >>
Mortality related to neoadjuvant therapy and surgery for stage III non-small-cell lung cancer.
Clamon, G.H., Parekh, K.R.; Clin Lung Cancer.
See more >>Memberships
American Society of Clinical Oncology